verywellhealth18h
Flu, COVID, and RSV: It's Peak Season
For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...
heraldsun.com.au6d
RSV vaccines are available for vulnerable adults and the ill. They just can’t afford them.
It is a potentially fatal virus that can lead to hospitalisations and death in infants, but also in elderly and chronically ill adults. Two RSV vaccines were approved for use in Australia last ...
RSV vaccines are available for vulnerable adults and the ill. They just can’t afford them.
Vulnerable and elderly Australians are missing out on protection against respiratory syncytial virus (RSV) because many can’t afford to pay $350 for a one-off vaccine.
FiercePharma22h
Pfizer harnesses COVID fluctuations to clinch Q4 gains as RSV vaccine sales plummet
After a period of unsteady sales for its key COVID-19 products, Pfizer now sees COVID-related revenue volatility as “largely ...
Vaccine safety alert: Jab rolled out to millions 'could cause neurological illness', health chiefs warn
US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is ...
Scientific American1d
How Bad Are COVID, Flu and RSV This Winter?
During the COVID pandemic, RSV showed a slightly odd pattern: like flu, it basically disappeared in the 2020–2021 season, ...
FierceBiotech6d
Shionogi's RSV antiviral reduces viral load in phase 2 trial of adults
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...